Search research articles
Contact Us
Filters
Showing results (61-70 of 250) with videos related to
Page
of 25
Sort By:
Frontiers in Oncology
|
June 1, 2016
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention
Katherine Karakasis, Julia V Burnier, Valerie Bowering, et al.
Cancer
|
October 4, 2014
Estimation of expectedness: predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer
Vincent Castonguay, Michelle K Wilson, Ivan Diaz-Padilla, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 4, 2020
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment
Michelle McMullen, Katherine Karakasis, Bienvenu Loembe, et al.
Current Oncology (Toronto, Ont.)
|
January 27, 2021
Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature
Lawrence Kasherman, Jeffrey Doi, Katherine Karakasis, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers
Ainhoa Madariaga, Gordon J S Rustin, Ronald J Buckanovich, et al.
Journal of Surgical Oncology
|
August 2, 2019
Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study
Jacob Korach, Nicoletta Colombo, Cesar Mendiola, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 1, 2020
Across barriers: poly ADP-ribose polymerase inhibitors beyond progression in high grade serous ovarian cancer with brain metastases
Lawrence Kasherman, Ainhoa Madariaga, Marjan Rouzbahman, et al.
The Lancet. Oncology
|
October 5, 2015
Discordance between the results and conclusions of ICON7 - Authors' reply
Amit M Oza, Adrian D Cook, Richard Kaplan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 3, 2018
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study
Frédéric Selle, Nicoletta Colombo, Jacob Korach, et al.
BMC Cancer
|
November 10, 2006
Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital
Jeremy Ho, Gregory R Pond, Colin Newman, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 250) with videos related to
Sort By:
Page
of 25
Frontiers in Oncology
|
June 1, 2016
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention
Katherine Karakasis, Julia V Burnier, Valerie Bowering, et al.
Cancer
|
October 4, 2014
Estimation of expectedness: predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer
Vincent Castonguay, Michelle K Wilson, Ivan Diaz-Padilla, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 4, 2020
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment
Michelle McMullen, Katherine Karakasis, Bienvenu Loembe, et al.
Current Oncology (Toronto, Ont.)
|
January 27, 2021
Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature
Lawrence Kasherman, Jeffrey Doi, Katherine Karakasis, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers
Ainhoa Madariaga, Gordon J S Rustin, Ronald J Buckanovich, et al.
Journal of Surgical Oncology
|
August 2, 2019
Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study
Jacob Korach, Nicoletta Colombo, Cesar Mendiola, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 1, 2020
Across barriers: poly ADP-ribose polymerase inhibitors beyond progression in high grade serous ovarian cancer with brain metastases
Lawrence Kasherman, Ainhoa Madariaga, Marjan Rouzbahman, et al.
The Lancet. Oncology
|
October 5, 2015
Discordance between the results and conclusions of ICON7 - Authors' reply
Amit M Oza, Adrian D Cook, Richard Kaplan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 3, 2018
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study
Frédéric Selle, Nicoletta Colombo, Jacob Korach, et al.
BMC Cancer
|
November 10, 2006
Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital
Jeremy Ho, Gregory R Pond, Colin Newman, et al.
Page
of 25